Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MD · against 1,336 other Healthcare companies
Ranked #249 of 1,337 · scores higher than 81% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including MD · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | MD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 6.9% | 1.5% | 87% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 10.0% | 4.2% | 80% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 9.2% | -1.0% | 92% | 20% | |
| Book yieldHigher is better · 1,306 reported | 36.3% | 37.9% | 48% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 249 | 10.9B CNY (≈$1.5B) | 81 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 72 |
| 249 | 13.2B CNY (≈$1.8B) | 81 | 71 |
| 249 | 2.5B USD | 81 | 79 |
| 249 | 16.9B THB (≈$474M) | 81 | 65 |
| 249 | 2.5B USD | 81 | 60 |
| 249 | 24.48T IDR (≈$1.5B) | 81 | 62 |
| 249 | 296M USD | 81 | 66 |
| 249 | 95.6B INR (≈$1.1B) | 81 | 54 |
| 249 | 3.0B EUR (≈$3.3B) | 81 | 62 |